Drug intelligence / Profile preview

7-epiclusianone

Development stage
Preclinical
Lead developer
Federal University of Alfenas
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

7-Epiclusianone is a naturally occurring prenylated benzophenone isolated from the fruits of *Garcinia brasiliensis* (also known as *Rheedia brasiliensis* or *Rheedia gardneriana*, commonly called bacupari in Brazilian folk medicine). It exhibits a broad spectrum of biological activities, including antineoplastic, antimicrobial, antiparasitic, and anti-inflammatory properties. In oncology, 7-epiclusianone has been shown to induce cell cycle arrest at the G1/S transition, promote cell senescence, and trigger apoptosis in various cancer cell lines, including breast and lung cancers. Mechanistically, it directly stabilizes and increases the polymerization rate of tubulin, and inhibits tyrosine kinases such as ALK (C1156Y mutant) and JAK3. Additionally, it has demonstrated antimicrobial activity against *Streptococcus mutans* by inhibiting glucosyltransferases (GtfB and GtfC) and F-ATPase, and antiparasitic activity against *Schistosoma mansoni* by inhibiting cytosolic superoxide dismutase (SmCtSOD).

Other names
7-epi7-epi-clusianone
02

Targets

F-ATPase (F-type H+-transporting ATPase)Gtf (Streptococcus mutans glucosyltransferase)ALK (Anaplastic lymphoma kinase receptor tyrosine kinase)Misfolded SOD1TUBB (Tubulin (alpha and beta subunits))JAK3 (Janus kinase 3)

Beyond the preview

Go deeper on 7-epiclusianone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 7-epiclusianone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call